Recalls from MACLEODS PHARMA USA, INC

• Macleods Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets (opens in a new tab)
  Moderate risk, FDA, Oct 26, 2026, Drug dissolving problem
• MacLeods Levothyroxine Sodium Tablets (opens in a new tab)
  Moderate risk, FDA, Mar 24, 2026, Wrong drug strength

Data: Recall Canary (opens in a new tab)